phosphoglycolate phosphatase
SEED: Phosphoglycolate phosphatase (EC 3.1.3.18)
KEGG: phosphoglycolate phosphatase
Top 20 experiments with the strongest phenotypes (|fitness| ≥ 0.1)
Or see all 52 experiments or choose conditions
| group | condition | fitness | t score | |
| survival | Survival; Treatment=FW300; TreatmentDuration=1week; Outgrowth=LB_Kan30 | -0.4 | -1.9 | compare |
| survival | Survival; Treatment=FW300; TreatmentDuration=1week; Outgrowth=LB_Kan30 | -0.3 | -1.5 | compare |
| survival | Survival; Treatment=FW300; TreatmentDuration=8weeks; Outgrowth=LB_kan30 | -0.3 | -1.1 | compare |
| survival | Survival; Treatment=20250415-M4-SZ1-UF; TreatmentDuration=1week; Outgrowth=LB_Kan30 | -0.2 | -0.8 | compare |
| no stress control | No stress control, anaerobic | -0.2 | -1.2 | compare |
| no stress control | No stress control, aerobic | -0.2 | -1.0 | compare |
| stress | Nickel (II) chloride 80 uM, anaerobic | -0.2 | -0.8 | compare |
| survival | Survival; Treatment=20250415-M4-SZ1-UF; TreatmentDuration=1week; Outgrowth=LB_Kan30 | -0.1 | -0.8 | compare |
| stress | Manganese (II) chloride tetrahydrate 50 uM, aerobic | +0.1 | +0.7 | compare |
| stress | Cadmium acetate 40 uM, aerobic | +0.1 | +0.8 | compare |
| stress | Aluminum potassium sulfate dodecahydrate 1 mM, aerobic | +0.1 | +0.8 | compare |
| stress | Cobalt chloride 60 uM, anaerobic | +0.1 | +0.7 | compare |
| survival | Survival; Treatment=FW300; TreatmentDuration=8weeks; Outgrowth=LB_kan30 | +0.1 | +0.5 | compare |
| survival | Survival; Treatment=20250415-M4-SZ1-UF; TreatmentDuration=1week; Outgrowth=LB_Kan30 | +0.1 | +0.8 | compare |
| stress | Nickel (II) chloride 80 uM, aerobic | +0.1 | +1.0 | compare |
| no stress control | No stress control, aerobic | +0.2 | +1.1 | compare |
| stress | Nickel (II) chloride 80 uM, aerobic | +0.2 | +1.1 | compare |
| stress | Cadmium acetate 40 uM, aerobic | +0.2 | +0.6 | compare |
| stress | Cobalt chloride 80 uM, aerobic | +0.3 | +1.5 | compare |
| stress | Cobalt chloride 80 uM, aerobic | +0.3 | +2.0 | compare |